Review



rabbit polyclonal anti gfp  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech rabbit polyclonal anti gfp
    Rabbit Polyclonal Anti Gfp, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1492 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti gfp/product/Proteintech
    Average 96 stars, based on 1492 article reviews
    rabbit polyclonal anti gfp - by Bioz Stars, 2026-03
    96/100 stars

    Images



    Similar Products

    98
    Developmental Studies Hybridoma Bank anti gfp rabbit polyclonal
    Anti Gfp Rabbit Polyclonal, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti gfp rabbit polyclonal/product/Developmental Studies Hybridoma Bank
    Average 98 stars, based on 1 article reviews
    anti gfp rabbit polyclonal - by Bioz Stars, 2026-03
    98/100 stars
      Buy from Supplier

    97
    TaKaRa rabbit anti gfp
    Rabbit Anti Gfp, supplied by TaKaRa, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti gfp/product/TaKaRa
    Average 97 stars, based on 1 article reviews
    rabbit anti gfp - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    96
    Proteintech rabbit polyclonal anti gfp
    Rabbit Polyclonal Anti Gfp, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti gfp/product/Proteintech
    Average 96 stars, based on 1 article reviews
    rabbit polyclonal anti gfp - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    Proteintech rabbit polyclonal anti gfp tag
    Rabbit Polyclonal Anti Gfp Tag, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti gfp tag/product/Proteintech
    Average 96 stars, based on 1 article reviews
    rabbit polyclonal anti gfp tag - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    AMS Biotechnology anti gfp rabbit polyclonal antibodies
    Anti Gfp Rabbit Polyclonal Antibodies, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti gfp rabbit polyclonal antibodies/product/AMS Biotechnology
    Average 96 stars, based on 1 article reviews
    anti gfp rabbit polyclonal antibodies - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    94
    Bio-Rad polyclonal anti gfp
    A) Immunoflourecence (IF) staining in adult mouse brain sections using <t>polyclonal</t> anti-mouse RNMT raised in rabbit. RNMT (Green), DAPI (blue), MAP2 (red). (B) RNMT IF using polyclonal anti-human RNMT raised in sheep and GFP-RNMT localisation in undifferentiated hiPSC, GFP (green), RNMT (red), DAPI (blue).
    Polyclonal Anti Gfp, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal anti gfp/product/Bio-Rad
    Average 94 stars, based on 1 article reviews
    polyclonal anti gfp - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    96
    Proteintech rabbit anti gfp polyclonal antibody
    A) Immunoflourecence (IF) staining in adult mouse brain sections using <t>polyclonal</t> anti-mouse RNMT raised in rabbit. RNMT (Green), DAPI (blue), MAP2 (red). (B) RNMT IF using polyclonal anti-human RNMT raised in sheep and GFP-RNMT localisation in undifferentiated hiPSC, GFP (green), RNMT (red), DAPI (blue).
    Rabbit Anti Gfp Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti gfp polyclonal antibody/product/Proteintech
    Average 96 stars, based on 1 article reviews
    rabbit anti gfp polyclonal antibody - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    AMS Biotechnology antibodies against gfp
    a , Filter trap of control polyQ19::YFP and expanded polyQ67::YFP (detected <t>by</t> <t>anti-GFP</t> antibody) expressed under neuronal-specific promoter in C. elegans . Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin loading control) to Q67 + Vector RNAi (mean ± s.e.m., n = 5 independent experiments). b , Percentage of nose touch responses/total trials per worm at days 1, 5 and 7 of adulthood ( n = 80 worms per condition; each worm was tested 10 times to determine the response percentage). The box plots represent the 25th–75th percentiles, the lines depict the median and the whiskers show the minimum–maximum values. c , Chemotaxis index toward 0.5% benzaldehyde at days 1, 5 and 7 of adulthood (mean ± s.e.m., n = 3 independent experiments; 65–206 worms were scored per condition for each independent experiment). In a – c , RNAi was initiated after development. d , Filter trap analysis of polyQ67::YFP aggregates (detected <t>by</t> <t>anti-GFP</t> antibody) in worms expressing endogenous WT or Ub-less mutant EPS-8(K524R/K583R/K621R) at days 1 and 3 of adulthood. Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated and total polyQ67 levels (corrected for α-tubulin) to day 1 adult Q67;EPS-8 (WT) worms (mean ± s.e.m., n = 4 independent experiments). e , Percentage of nose touch responses/total trials per worm at days 1 and 3 of adulthood ( n = 50 worms per condition). The box plots represent the 25th–75th percentiles, the lines depict the median and the whiskers show the minimum–maximum values. f , Chemotaxis index toward 0.5% benzaldehyde at days 1 and 3 of adulthood (mean ± s.e.m., n = 3 independent experiments; 68–204 worms were scored per condition for each independent experiment). Statistical comparisons were made by one-way analysis of variance (ANOVA) with Dunnett’s multiple comparisons test ( a ), two-way ANOVA with Sidakʼs multiple comparisons test ( b , c ) and two-way ANOVA with Fisher’s least significant difference (LSD) test ( d – f ).
    Antibodies Against Gfp, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against gfp/product/AMS Biotechnology
    Average 96 stars, based on 1 article reviews
    antibodies against gfp - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    Image Search Results


    A) Immunoflourecence (IF) staining in adult mouse brain sections using polyclonal anti-mouse RNMT raised in rabbit. RNMT (Green), DAPI (blue), MAP2 (red). (B) RNMT IF using polyclonal anti-human RNMT raised in sheep and GFP-RNMT localisation in undifferentiated hiPSC, GFP (green), RNMT (red), DAPI (blue).

    Journal: bioRxiv

    Article Title: CaMKII-RNMT axis directs activity-dependent control of RNA dynamics in neurons

    doi: 10.1101/2025.10.30.685591

    Figure Lengend Snippet: A) Immunoflourecence (IF) staining in adult mouse brain sections using polyclonal anti-mouse RNMT raised in rabbit. RNMT (Green), DAPI (blue), MAP2 (red). (B) RNMT IF using polyclonal anti-human RNMT raised in sheep and GFP-RNMT localisation in undifferentiated hiPSC, GFP (green), RNMT (red), DAPI (blue).

    Article Snippet: Immunoprecipitations were carried out overnight at 4 °C using 1 μg of polyclonal anti-GFP (Bio-Rad) antibody and 10 μl of protein G Dynabeads (Thermofisher Scientific).

    Techniques: Staining

    (A) Endogenous RNMT and GFP-RNMT localisation in hiPSC-derived Dopaminergic (DA) neurons. GFP (green), RNMT staining using polyclonal anti-human RNMT raised in sheep (red), DAPI (blue). B) Primary murine neurons transfected with GFP-RNMT visualised at 7 days in vitro (DIV). GFP-RNMT expression visualised directly by fluorescence microscopy. C) RNMT in Synapsin I-positive neurites and MAP2-positive dendrites in DA neurons. RNMT staining using polyclonal anti-human RNMT raised in sheep (green), MAP2 (red), Synapsin I (red), DAPI (blue).

    Journal: bioRxiv

    Article Title: CaMKII-RNMT axis directs activity-dependent control of RNA dynamics in neurons

    doi: 10.1101/2025.10.30.685591

    Figure Lengend Snippet: (A) Endogenous RNMT and GFP-RNMT localisation in hiPSC-derived Dopaminergic (DA) neurons. GFP (green), RNMT staining using polyclonal anti-human RNMT raised in sheep (red), DAPI (blue). B) Primary murine neurons transfected with GFP-RNMT visualised at 7 days in vitro (DIV). GFP-RNMT expression visualised directly by fluorescence microscopy. C) RNMT in Synapsin I-positive neurites and MAP2-positive dendrites in DA neurons. RNMT staining using polyclonal anti-human RNMT raised in sheep (green), MAP2 (red), Synapsin I (red), DAPI (blue).

    Article Snippet: Immunoprecipitations were carried out overnight at 4 °C using 1 μg of polyclonal anti-GFP (Bio-Rad) antibody and 10 μl of protein G Dynabeads (Thermofisher Scientific).

    Techniques: Derivative Assay, Staining, Transfection, In Vitro, Expressing, Fluorescence, Microscopy

    a , Filter trap of control polyQ19::YFP and expanded polyQ67::YFP (detected by anti-GFP antibody) expressed under neuronal-specific promoter in C. elegans . Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin loading control) to Q67 + Vector RNAi (mean ± s.e.m., n = 5 independent experiments). b , Percentage of nose touch responses/total trials per worm at days 1, 5 and 7 of adulthood ( n = 80 worms per condition; each worm was tested 10 times to determine the response percentage). The box plots represent the 25th–75th percentiles, the lines depict the median and the whiskers show the minimum–maximum values. c , Chemotaxis index toward 0.5% benzaldehyde at days 1, 5 and 7 of adulthood (mean ± s.e.m., n = 3 independent experiments; 65–206 worms were scored per condition for each independent experiment). In a – c , RNAi was initiated after development. d , Filter trap analysis of polyQ67::YFP aggregates (detected by anti-GFP antibody) in worms expressing endogenous WT or Ub-less mutant EPS-8(K524R/K583R/K621R) at days 1 and 3 of adulthood. Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated and total polyQ67 levels (corrected for α-tubulin) to day 1 adult Q67;EPS-8 (WT) worms (mean ± s.e.m., n = 4 independent experiments). e , Percentage of nose touch responses/total trials per worm at days 1 and 3 of adulthood ( n = 50 worms per condition). The box plots represent the 25th–75th percentiles, the lines depict the median and the whiskers show the minimum–maximum values. f , Chemotaxis index toward 0.5% benzaldehyde at days 1 and 3 of adulthood (mean ± s.e.m., n = 3 independent experiments; 68–204 worms were scored per condition for each independent experiment). Statistical comparisons were made by one-way analysis of variance (ANOVA) with Dunnett’s multiple comparisons test ( a ), two-way ANOVA with Sidakʼs multiple comparisons test ( b , c ) and two-way ANOVA with Fisher’s least significant difference (LSD) test ( d – f ).

    Journal: Nature Aging

    Article Title: The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation

    doi: 10.1038/s43587-025-00943-w

    Figure Lengend Snippet: a , Filter trap of control polyQ19::YFP and expanded polyQ67::YFP (detected by anti-GFP antibody) expressed under neuronal-specific promoter in C. elegans . Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin loading control) to Q67 + Vector RNAi (mean ± s.e.m., n = 5 independent experiments). b , Percentage of nose touch responses/total trials per worm at days 1, 5 and 7 of adulthood ( n = 80 worms per condition; each worm was tested 10 times to determine the response percentage). The box plots represent the 25th–75th percentiles, the lines depict the median and the whiskers show the minimum–maximum values. c , Chemotaxis index toward 0.5% benzaldehyde at days 1, 5 and 7 of adulthood (mean ± s.e.m., n = 3 independent experiments; 65–206 worms were scored per condition for each independent experiment). In a – c , RNAi was initiated after development. d , Filter trap analysis of polyQ67::YFP aggregates (detected by anti-GFP antibody) in worms expressing endogenous WT or Ub-less mutant EPS-8(K524R/K583R/K621R) at days 1 and 3 of adulthood. Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated and total polyQ67 levels (corrected for α-tubulin) to day 1 adult Q67;EPS-8 (WT) worms (mean ± s.e.m., n = 4 independent experiments). e , Percentage of nose touch responses/total trials per worm at days 1 and 3 of adulthood ( n = 50 worms per condition). The box plots represent the 25th–75th percentiles, the lines depict the median and the whiskers show the minimum–maximum values. f , Chemotaxis index toward 0.5% benzaldehyde at days 1 and 3 of adulthood (mean ± s.e.m., n = 3 independent experiments; 68–204 worms were scored per condition for each independent experiment). Statistical comparisons were made by one-way analysis of variance (ANOVA) with Dunnett’s multiple comparisons test ( a ), two-way ANOVA with Sidakʼs multiple comparisons test ( b , c ) and two-way ANOVA with Fisher’s least significant difference (LSD) test ( d – f ).

    Article Snippet: For both filter trap and western blot analyses of C. elegans , immunoblotting was performed with antibodies against GFP (AMSBIO, TP401, dilution 1:5,000), FUS (Abcam, ab154141, clone CL0190, 1:1,000) and TDP-43 (Abcam, ab225710, 1:1,000).

    Techniques: Control, SDS Page, Plasmid Preparation, Chemotaxis Assay, Expressing, Mutagenesis

    a , eps-8 knockout reduces polyQ aggregation. Left: Filter trap assay with anti-GFP in day-5 adult worms. Right: SDS–PAGE with antibodies to GFP and α-tubulin loading control. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin) to Q67 (mean ± s.e.m., n = 6 independent experiments). b , Western blot analysis of day-5 adult worms expressing polyQ19::YFP or polyQ67::YFP peptides in neurons, using antibodies against GFP and α-tubulin loading control. Worms were treated with RNAi after development. Graph represents the relative percentage values of insoluble polyQ levels (corrected for α-tubulin) to Q19 + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). c , Filter trap assay with anti-GFP in day-5 adult polyQ67::YFP worms following RNAi treatment against RAC orthologs after development. Right: SDS–PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin) to Vector RNAi (mean ± s.e.m., n = 3 independent experiments). d , Knockdown of IFB-2 after development does not reduce aggregation of polyQ-expanded peptides in the neurons of day-5 adult worms. Representative of 7 independent experiments. e , Knockdown of IFB-2 after development does not decrease polyQ-expanded aggregation in the muscle of day-5 adult worms. Representative of 3 independent experiments. f , Knockdown of IFB-2 after development does not decrease polyQ-expanded aggregation in the intestine of day-5 adult worms. Representative of 3 independent experiments. g , Filter trap of neuronal polyQ67::YFP aggregation with anti-GFP in day-5 adult worms upon neuronal knockdown of eps-8 and RAC orthologs. Right: SDS–PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin) to Vector RNAi (mean ± s.e.m., n = 4 independent experiments). Statistical comparisons were made by two-tailed Wilcoxon signed-rank test ( a ), two-way ANOVA with Fisher’s LSD test ( b ), one-way ANOVA with Tukey’s multiple-comparison test ( c ), and one-way ANOVA with Dunnett’s multiple-comparison test ( g ).

    Journal: Nature Aging

    Article Title: The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation

    doi: 10.1038/s43587-025-00943-w

    Figure Lengend Snippet: a , eps-8 knockout reduces polyQ aggregation. Left: Filter trap assay with anti-GFP in day-5 adult worms. Right: SDS–PAGE with antibodies to GFP and α-tubulin loading control. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin) to Q67 (mean ± s.e.m., n = 6 independent experiments). b , Western blot analysis of day-5 adult worms expressing polyQ19::YFP or polyQ67::YFP peptides in neurons, using antibodies against GFP and α-tubulin loading control. Worms were treated with RNAi after development. Graph represents the relative percentage values of insoluble polyQ levels (corrected for α-tubulin) to Q19 + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). c , Filter trap assay with anti-GFP in day-5 adult polyQ67::YFP worms following RNAi treatment against RAC orthologs after development. Right: SDS–PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin) to Vector RNAi (mean ± s.e.m., n = 3 independent experiments). d , Knockdown of IFB-2 after development does not reduce aggregation of polyQ-expanded peptides in the neurons of day-5 adult worms. Representative of 7 independent experiments. e , Knockdown of IFB-2 after development does not decrease polyQ-expanded aggregation in the muscle of day-5 adult worms. Representative of 3 independent experiments. f , Knockdown of IFB-2 after development does not decrease polyQ-expanded aggregation in the intestine of day-5 adult worms. Representative of 3 independent experiments. g , Filter trap of neuronal polyQ67::YFP aggregation with anti-GFP in day-5 adult worms upon neuronal knockdown of eps-8 and RAC orthologs. Right: SDS–PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin) to Vector RNAi (mean ± s.e.m., n = 4 independent experiments). Statistical comparisons were made by two-tailed Wilcoxon signed-rank test ( a ), two-way ANOVA with Fisher’s LSD test ( b ), one-way ANOVA with Tukey’s multiple-comparison test ( c ), and one-way ANOVA with Dunnett’s multiple-comparison test ( g ).

    Article Snippet: For both filter trap and western blot analyses of C. elegans , immunoblotting was performed with antibodies against GFP (AMSBIO, TP401, dilution 1:5,000), FUS (Abcam, ab154141, clone CL0190, 1:1,000) and TDP-43 (Abcam, ab225710, 1:1,000).

    Techniques: Knock-Out, TRAP Assay, SDS Page, Control, Western Blot, Expressing, Plasmid Preparation, Knockdown, Two Tailed Test, Comparison

    a , Filter trap of day 5 adult C. elegans expressing polyQ44::YFP in the intestine (detected by anti-GFP antibody). Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ44 and total polyQ44 levels (corrected for α-tubulin) to Vector RNAi (mean ± s.e.m., n = 4 independent experiments). b , Filter trap of day 5 adult C. elegans expressing polyQ40::YFP in the muscle (detected by anti-GFP antibody). Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ40 and total polyQ40 levels (corrected for α-tubulin) to Vector RNAi (mean ± s.e.m., n = 4 independent experiments). c , Body bends per second in worms expressing polyQ40 in the muscle at days 1, 5 and 7 of adulthood (day 1 (D1) + Vector RNAi: n = 41 worms; D1 + eps-8 RNAi: n = 41; D1 + mig-2 RNAi: n = 46; D1 + rac-2 RNAi: n = 44; D5 + Vector RNAi: n = 58 worms; D5 + eps-8 RNAi: n = 52; D5 + mig-2 RNAi: n = 48; D5 + rac-2 RNAi: n = 59; D7 + Vector RNAi: n = 42 worms; D7 + eps-8 RNAi: n = 49; D7 + mig-2 RNAi: n = 54; D7 + rac-2 RNAi: n = 49). The box plots represent the 25th–75th percentiles, the line depicts the median and the whiskers show the minimum–maximum values. d , Knockdown of eps-8 or RAC orthologs ameliorates aggregation of ALS-related mutant FUS P525L variant in the neurons of day 5 adult C. elegans (detected by anti-FUS antibody). Right: SDS-PAGE with antibodies to FUS and α-tubulin. Graphs represent the relative percentage values of aggregated and total FUS P525L protein levels (corrected for α-tubulin) to Vector RNAi (mean ± s.e.m., n = 4 independent experiments). e , Knockdown of eps-8 or RAC orthologs ameliorates aggregation of ALS-related mutant TDP-43 M337V variant in the neurons of day 5 adult worms (detected by anti-TDP-43 antibody). Right: SDS-PAGE with antibodies to TDP-43 and α-tubulin. Graphs represent the relative percentage values of aggregated and total TDP-43 M337V protein levels (corrected for α-tubulin) to Vector RNAi (mean ± s.e.m., n = 4 independent experiments). f , Percentage of nose touch responses/total trials in WT worms and transgenic worms expressing WT FUS or ALS-related mutant FUS R522G and FUS P525L variants (D1: n = 40 worms per condition; D5: n = 80; D7: n = 80). The box plots represent the 25th–75th percentiles, the line depicts the median and the whiskers show the minimum–maximum values. g , Chemotaxis index of FUS-ALS worm models toward 0.5% benzaldehyde at day 5 of adulthood (mean ± s.e.m., n = 3 independent experiments; 72–148 worms were scored per condition for each independent experiment). h , Percentage of nose touch responses/total trials in WT worms and transgenic worms expressing WT TDP-43 or ALS-related mutant TDP-43 M337V variant (D1: n = 30 worms per condition; D5: n = 70; D7: n = 70). The box plots represent the 25th–75th percentiles, the line depicts the median and the whiskers show the minimum–maximum values. i , Chemotaxis index of TDP-43 ALS worm models toward 0.5% benzaldehyde at day 5 of adulthood (mean ± s.e.m., n = 3 independent experiments; 48–439 worms were scored per condition for each independent experiment). j , Number of GABAergic neurons ( unc-25p ::GFP) in the nerve cord of TDP-43 ALS worms at day 5 of adulthood (mean ± s.e.m., TDP-43(WT) + Vector RNAi: n = 88 worms from two independent experiments; TDP-43(WT) + eps-8 RNAi: n = 50; TDP-43(WT) + mig-2 RNAi: n = 49; TDP-43(WT) + rac-2 RNAi: n = 49; TDP-43(M337V) + Vector RNAi: n = 73; TDP-43(M337V) + eps-8 RNAi: n = 45; TDP-43(M337V) + mig-2 RNAi: n = 53; TDP-43(M337V) + rac-2 RNAi: n = 49). The box plots represent the 25th–75th percentiles, the line depicts the median and the whiskers show the minimum–maximum values. k , Graph represents the percentage of worms displaying discontinuities in the nerve cord at day 5 of adulthood (percentage from 49–88 worms per condition from two independent experiments). Statistical comparisons were made by one-way ANOVA with Dunnett’s multiple comparisons test ( a , b , d , e ), two-way ANOVA with Sidakʼs multiple comparisons test ( c , f – j ) and two-sided Fisher’s exact test from contingency table analysis of number of worms displaying discontinuities in the nerve cord ( k ).

    Journal: Nature Aging

    Article Title: The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation

    doi: 10.1038/s43587-025-00943-w

    Figure Lengend Snippet: a , Filter trap of day 5 adult C. elegans expressing polyQ44::YFP in the intestine (detected by anti-GFP antibody). Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ44 and total polyQ44 levels (corrected for α-tubulin) to Vector RNAi (mean ± s.e.m., n = 4 independent experiments). b , Filter trap of day 5 adult C. elegans expressing polyQ40::YFP in the muscle (detected by anti-GFP antibody). Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ40 and total polyQ40 levels (corrected for α-tubulin) to Vector RNAi (mean ± s.e.m., n = 4 independent experiments). c , Body bends per second in worms expressing polyQ40 in the muscle at days 1, 5 and 7 of adulthood (day 1 (D1) + Vector RNAi: n = 41 worms; D1 + eps-8 RNAi: n = 41; D1 + mig-2 RNAi: n = 46; D1 + rac-2 RNAi: n = 44; D5 + Vector RNAi: n = 58 worms; D5 + eps-8 RNAi: n = 52; D5 + mig-2 RNAi: n = 48; D5 + rac-2 RNAi: n = 59; D7 + Vector RNAi: n = 42 worms; D7 + eps-8 RNAi: n = 49; D7 + mig-2 RNAi: n = 54; D7 + rac-2 RNAi: n = 49). The box plots represent the 25th–75th percentiles, the line depicts the median and the whiskers show the minimum–maximum values. d , Knockdown of eps-8 or RAC orthologs ameliorates aggregation of ALS-related mutant FUS P525L variant in the neurons of day 5 adult C. elegans (detected by anti-FUS antibody). Right: SDS-PAGE with antibodies to FUS and α-tubulin. Graphs represent the relative percentage values of aggregated and total FUS P525L protein levels (corrected for α-tubulin) to Vector RNAi (mean ± s.e.m., n = 4 independent experiments). e , Knockdown of eps-8 or RAC orthologs ameliorates aggregation of ALS-related mutant TDP-43 M337V variant in the neurons of day 5 adult worms (detected by anti-TDP-43 antibody). Right: SDS-PAGE with antibodies to TDP-43 and α-tubulin. Graphs represent the relative percentage values of aggregated and total TDP-43 M337V protein levels (corrected for α-tubulin) to Vector RNAi (mean ± s.e.m., n = 4 independent experiments). f , Percentage of nose touch responses/total trials in WT worms and transgenic worms expressing WT FUS or ALS-related mutant FUS R522G and FUS P525L variants (D1: n = 40 worms per condition; D5: n = 80; D7: n = 80). The box plots represent the 25th–75th percentiles, the line depicts the median and the whiskers show the minimum–maximum values. g , Chemotaxis index of FUS-ALS worm models toward 0.5% benzaldehyde at day 5 of adulthood (mean ± s.e.m., n = 3 independent experiments; 72–148 worms were scored per condition for each independent experiment). h , Percentage of nose touch responses/total trials in WT worms and transgenic worms expressing WT TDP-43 or ALS-related mutant TDP-43 M337V variant (D1: n = 30 worms per condition; D5: n = 70; D7: n = 70). The box plots represent the 25th–75th percentiles, the line depicts the median and the whiskers show the minimum–maximum values. i , Chemotaxis index of TDP-43 ALS worm models toward 0.5% benzaldehyde at day 5 of adulthood (mean ± s.e.m., n = 3 independent experiments; 48–439 worms were scored per condition for each independent experiment). j , Number of GABAergic neurons ( unc-25p ::GFP) in the nerve cord of TDP-43 ALS worms at day 5 of adulthood (mean ± s.e.m., TDP-43(WT) + Vector RNAi: n = 88 worms from two independent experiments; TDP-43(WT) + eps-8 RNAi: n = 50; TDP-43(WT) + mig-2 RNAi: n = 49; TDP-43(WT) + rac-2 RNAi: n = 49; TDP-43(M337V) + Vector RNAi: n = 73; TDP-43(M337V) + eps-8 RNAi: n = 45; TDP-43(M337V) + mig-2 RNAi: n = 53; TDP-43(M337V) + rac-2 RNAi: n = 49). The box plots represent the 25th–75th percentiles, the line depicts the median and the whiskers show the minimum–maximum values. k , Graph represents the percentage of worms displaying discontinuities in the nerve cord at day 5 of adulthood (percentage from 49–88 worms per condition from two independent experiments). Statistical comparisons were made by one-way ANOVA with Dunnett’s multiple comparisons test ( a , b , d , e ), two-way ANOVA with Sidakʼs multiple comparisons test ( c , f – j ) and two-sided Fisher’s exact test from contingency table analysis of number of worms displaying discontinuities in the nerve cord ( k ).

    Article Snippet: For both filter trap and western blot analyses of C. elegans , immunoblotting was performed with antibodies against GFP (AMSBIO, TP401, dilution 1:5,000), FUS (Abcam, ab154141, clone CL0190, 1:1,000) and TDP-43 (Abcam, ab225710, 1:1,000).

    Techniques: Expressing, SDS Page, Plasmid Preparation, Knockdown, Mutagenesis, Variant Assay, Transgenic Assay, Chemotaxis Assay

    a , Filter trap analysis of muscle polyQ40::YFP aggregates (detected by anti-GFP antibody) in worms expressing endogenous wild-type (WT) or Ub-less mutant EPS-8(K524R/K583R/K621R) at day 1 and 3 of adulthood. Right: SDS–PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated and total polyQ40 levels (corrected for α-tubulin) to day-1 adult Q40;EPS-8 (WT) worms (mean ± s.e.m., n = 3 independent experiments). b , Body bends per second in wild-type EPS-8 and Ub-less EPS-8 worms expressing polyQ40 in muscle cells. Day 1 (D1) EPS-8(WT): n = 46 worms; D1 EPS-8(Ub-less): n = 41; D3 EPS-8(WT): n = 51; D3 EPS-8(Ub-less): n = 45. c , Body bends per second in wild-type worms and transgenic worms expressing wild-type TDP-43 (WT) or ALS-related mutant TDP-43 M337V variant. D1 wild-type + Vector RNAi: n = 44 worms; D1 wild-type + eps-8 RNAi: n = 47; D1 wild-type + mig-2 RNAi: n = 41; D1 wild-type + rac-2 RNAi: n = 42; D1 TDP-43(WT) + Vector RNAi: n = 45; D1 TDP-43(WT) + eps-8 RNAi: n = 41; D1 TDP-43(WT) + mig-2 RNAi: n = 47; D1 TDP-43(WT) + rac-2 RNAi: n = 44; D1 TDP-43(M337V) + Vector RNAi: n = 45; D1 TDP-43(M337V) + eps-8 RNAi: n = 44; D1 TDP-43(M337V) + mig-2 RNAi: n = 43; D1 TDP-43(M337V) + rac-2 RNAi: n = 41; D5 wild-type + Vector RNAi: n = 42 worms; D5 wild-type + eps-8 RNAi: n = 35; D5 wild-type + mig-2 RNAi: n = 38; D5 wild-type + rac-2 RNAi: n = 36; D5 TDP-43(WT) + Vector RNAi: n = 38; D5 TDP-43(WT) + eps-8 RNAi: n = 39; D5 TDP-43(WT) + mig-2 RNAi: n = 34; D5 TDP-43(WT) + rac-2 RNAi: n = 38; D5 TDP-43(M337V) + Vector RNAi: n = 34; D5 TDP-43(M337V) + eps-8 RNAi: n = 39; D5 TDP-43(M337V) + mig-2 RNAi: n = 35; D5 TDP-43(M337V) + rac-2 RNAi: n = 38. In b,c , the box plots represent the 25th–75th percentiles, the line depicts the median and the whiskers show the minimum–maximum values. d , Chemotaxis index of FUS ALS worm models toward 0.5% benzaldehyde at day 1 of adulthood (mean ± s.e.m., n = 3 independent experiments, 66-174 worms were scored per condition for each independent experiment). No significant differences were observed. e , Chemotaxis index of TDP-43 ALS worm models toward 0.5% benzaldehyde at day 1 of adulthood (mean ± s.e.m., n = 3 independent experiments, 48-257 worms were scored per condition for each independent experiment). No significant differences were observed. In all the experiments, RNAi was initiated after development. Statistical comparisons were by two-way ANOVA with Fisher’s LSD test ( a,b ) and two-way ANOVA with Šidák multiple-comparison test ( c,d,e ).

    Journal: Nature Aging

    Article Title: The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation

    doi: 10.1038/s43587-025-00943-w

    Figure Lengend Snippet: a , Filter trap analysis of muscle polyQ40::YFP aggregates (detected by anti-GFP antibody) in worms expressing endogenous wild-type (WT) or Ub-less mutant EPS-8(K524R/K583R/K621R) at day 1 and 3 of adulthood. Right: SDS–PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated and total polyQ40 levels (corrected for α-tubulin) to day-1 adult Q40;EPS-8 (WT) worms (mean ± s.e.m., n = 3 independent experiments). b , Body bends per second in wild-type EPS-8 and Ub-less EPS-8 worms expressing polyQ40 in muscle cells. Day 1 (D1) EPS-8(WT): n = 46 worms; D1 EPS-8(Ub-less): n = 41; D3 EPS-8(WT): n = 51; D3 EPS-8(Ub-less): n = 45. c , Body bends per second in wild-type worms and transgenic worms expressing wild-type TDP-43 (WT) or ALS-related mutant TDP-43 M337V variant. D1 wild-type + Vector RNAi: n = 44 worms; D1 wild-type + eps-8 RNAi: n = 47; D1 wild-type + mig-2 RNAi: n = 41; D1 wild-type + rac-2 RNAi: n = 42; D1 TDP-43(WT) + Vector RNAi: n = 45; D1 TDP-43(WT) + eps-8 RNAi: n = 41; D1 TDP-43(WT) + mig-2 RNAi: n = 47; D1 TDP-43(WT) + rac-2 RNAi: n = 44; D1 TDP-43(M337V) + Vector RNAi: n = 45; D1 TDP-43(M337V) + eps-8 RNAi: n = 44; D1 TDP-43(M337V) + mig-2 RNAi: n = 43; D1 TDP-43(M337V) + rac-2 RNAi: n = 41; D5 wild-type + Vector RNAi: n = 42 worms; D5 wild-type + eps-8 RNAi: n = 35; D5 wild-type + mig-2 RNAi: n = 38; D5 wild-type + rac-2 RNAi: n = 36; D5 TDP-43(WT) + Vector RNAi: n = 38; D5 TDP-43(WT) + eps-8 RNAi: n = 39; D5 TDP-43(WT) + mig-2 RNAi: n = 34; D5 TDP-43(WT) + rac-2 RNAi: n = 38; D5 TDP-43(M337V) + Vector RNAi: n = 34; D5 TDP-43(M337V) + eps-8 RNAi: n = 39; D5 TDP-43(M337V) + mig-2 RNAi: n = 35; D5 TDP-43(M337V) + rac-2 RNAi: n = 38. In b,c , the box plots represent the 25th–75th percentiles, the line depicts the median and the whiskers show the minimum–maximum values. d , Chemotaxis index of FUS ALS worm models toward 0.5% benzaldehyde at day 1 of adulthood (mean ± s.e.m., n = 3 independent experiments, 66-174 worms were scored per condition for each independent experiment). No significant differences were observed. e , Chemotaxis index of TDP-43 ALS worm models toward 0.5% benzaldehyde at day 1 of adulthood (mean ± s.e.m., n = 3 independent experiments, 48-257 worms were scored per condition for each independent experiment). No significant differences were observed. In all the experiments, RNAi was initiated after development. Statistical comparisons were by two-way ANOVA with Fisher’s LSD test ( a,b ) and two-way ANOVA with Šidák multiple-comparison test ( c,d,e ).

    Article Snippet: For both filter trap and western blot analyses of C. elegans , immunoblotting was performed with antibodies against GFP (AMSBIO, TP401, dilution 1:5,000), FUS (Abcam, ab154141, clone CL0190, 1:1,000) and TDP-43 (Abcam, ab225710, 1:1,000).

    Techniques: Expressing, Mutagenesis, SDS Page, Transgenic Assay, Variant Assay, Plasmid Preparation, Chemotaxis Assay, Comparison

    a , Filter trap with anti-GFP antibody of HEK293 human cells expressing Q23-HTT-GFP or Q100-HTT-GFP treated with either non-targeting (NT) shRNA or independent shRNA constructs against EPS8. Right: SDS-PAGE with antibodies to HTT, EPS8 and β-actin loading control. Graphs represent the relative percentage values of aggregated and total Q100-HTT protein levels (corrected for β-actin) to NT shRNA Q100-HTT cells (mean ± s.e.m., n = 5 independent experiments). b , Filter trap with anti-TDP-43 antibody of HEK293 cells expressing WT TDP-43 or ALS-related mutant TDP-43 A382T . Right: SDS-PAGE with antibodies to TDP-43, EPS8 and β-actin loading control. Graphs represent the relative percentage values of aggregated and total TDP-43 A382T protein levels (corrected for β-actin) to NT shRNA TDP-43 A382T cells (mean ± s.e.m., n = 4 independent experiments). c , Filter trap with anti-FUS antibody of HEK293 cells expressing WT FUS or ALS-related mutant FUS P525L . Right: SDS-PAGE with antibodies to FUS, EPS8 and β-actin loading control. Graph represents the relative percentage values of aggregated and total FUS P525L protein levels (corrected for β-actin) to NT shRNA FUS P525L cells (mean ± s.e.m., n = 4 independent experiments). d , Immunocytochemistry of FUS(P525L) ALS iPSC-derived motor neurons with anti-cleaved caspase-3 (red), anti-MAP2 (green) and Hoechst (nucleus, blue). Scale bar, 10 µm. Graph represents the percentage of cleaved caspase-3-positive cells/total nuclei (mean ± s.e.m. of nine biological replicates from two independent experiments, NT shRNA: 383 total nuclei and EPS8 shRNA 2: 192 total nuclei). e , Western blot analysis of FUS(P525L) ALS iPSC motor neurons with antibodies to phosphorylated RIP (P-RIP) at Ser166, total RIP and β-actin loading control. Graph represents the relative percentage ratio of P-RIP/total RIP levels to NT shRNA (mean ± s.e.m., n = 3 independent experiments). f , Increased aggregation of Q100-HTT-GFP (detected by anti-GFP antibody) in HEK293 cells overexpressing (OE) EPS8. Right: SDS-PAGE with antibodies to HTT, EPS8 and β-actin. Graphs represent the relative percentage values of aggregated and total Q100-HTT (corrected for β-actin) levels to Q100-HTT cells + empty vector (mean ± s.e.m., n = 6 independent experiments). g , Overexpression of EPS8 increases aggregation of mutant TDP-43 A382T (detected by anti-TDP-43 antibody) in HEK293 cells. Right: SDS-PAGE with antibodies to TDP-43, EPS8 and β-actin. Graphs represent the relative percentage values of aggregated and total TDP-43 A382T protein levels (corrected for β-actin) to TDP-43 A382T cells + empty vector (mean ± s.e.m., n = 6 independent experiments). h , Filter trap with anti-GFP antibody of HEK293 human cells expressing control Q23-HTT-GFP or aggregation-prone Q100-HTT-GFP. The treatment with 2 U ml −1 RAC activator (6 hours) hastens aggregation of Q100-HTT-GFP. Right: SDS-PAGE with antibodies to HTT and β-actin. Graphs represent the relative percentage of aggregated and total HTT-GFP levels (corrected for β-actin) to Q23-HTT-GFP (PBS vehicle control) cells (mean ± s.e.m., n = 4 independent experiments). Statistical comparisons were made by one-way ANOVA with Dunnett’s multiple comparisons test ( a – c , e ), two-sided t -test for unpaired samples ( d ), two-tailed Wilcoxon signed-rank test ( f , g ) and two-way ANOVA with Fisher’s LSD test ( h ).

    Journal: Nature Aging

    Article Title: The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation

    doi: 10.1038/s43587-025-00943-w

    Figure Lengend Snippet: a , Filter trap with anti-GFP antibody of HEK293 human cells expressing Q23-HTT-GFP or Q100-HTT-GFP treated with either non-targeting (NT) shRNA or independent shRNA constructs against EPS8. Right: SDS-PAGE with antibodies to HTT, EPS8 and β-actin loading control. Graphs represent the relative percentage values of aggregated and total Q100-HTT protein levels (corrected for β-actin) to NT shRNA Q100-HTT cells (mean ± s.e.m., n = 5 independent experiments). b , Filter trap with anti-TDP-43 antibody of HEK293 cells expressing WT TDP-43 or ALS-related mutant TDP-43 A382T . Right: SDS-PAGE with antibodies to TDP-43, EPS8 and β-actin loading control. Graphs represent the relative percentage values of aggregated and total TDP-43 A382T protein levels (corrected for β-actin) to NT shRNA TDP-43 A382T cells (mean ± s.e.m., n = 4 independent experiments). c , Filter trap with anti-FUS antibody of HEK293 cells expressing WT FUS or ALS-related mutant FUS P525L . Right: SDS-PAGE with antibodies to FUS, EPS8 and β-actin loading control. Graph represents the relative percentage values of aggregated and total FUS P525L protein levels (corrected for β-actin) to NT shRNA FUS P525L cells (mean ± s.e.m., n = 4 independent experiments). d , Immunocytochemistry of FUS(P525L) ALS iPSC-derived motor neurons with anti-cleaved caspase-3 (red), anti-MAP2 (green) and Hoechst (nucleus, blue). Scale bar, 10 µm. Graph represents the percentage of cleaved caspase-3-positive cells/total nuclei (mean ± s.e.m. of nine biological replicates from two independent experiments, NT shRNA: 383 total nuclei and EPS8 shRNA 2: 192 total nuclei). e , Western blot analysis of FUS(P525L) ALS iPSC motor neurons with antibodies to phosphorylated RIP (P-RIP) at Ser166, total RIP and β-actin loading control. Graph represents the relative percentage ratio of P-RIP/total RIP levels to NT shRNA (mean ± s.e.m., n = 3 independent experiments). f , Increased aggregation of Q100-HTT-GFP (detected by anti-GFP antibody) in HEK293 cells overexpressing (OE) EPS8. Right: SDS-PAGE with antibodies to HTT, EPS8 and β-actin. Graphs represent the relative percentage values of aggregated and total Q100-HTT (corrected for β-actin) levels to Q100-HTT cells + empty vector (mean ± s.e.m., n = 6 independent experiments). g , Overexpression of EPS8 increases aggregation of mutant TDP-43 A382T (detected by anti-TDP-43 antibody) in HEK293 cells. Right: SDS-PAGE with antibodies to TDP-43, EPS8 and β-actin. Graphs represent the relative percentage values of aggregated and total TDP-43 A382T protein levels (corrected for β-actin) to TDP-43 A382T cells + empty vector (mean ± s.e.m., n = 6 independent experiments). h , Filter trap with anti-GFP antibody of HEK293 human cells expressing control Q23-HTT-GFP or aggregation-prone Q100-HTT-GFP. The treatment with 2 U ml −1 RAC activator (6 hours) hastens aggregation of Q100-HTT-GFP. Right: SDS-PAGE with antibodies to HTT and β-actin. Graphs represent the relative percentage of aggregated and total HTT-GFP levels (corrected for β-actin) to Q23-HTT-GFP (PBS vehicle control) cells (mean ± s.e.m., n = 4 independent experiments). Statistical comparisons were made by one-way ANOVA with Dunnett’s multiple comparisons test ( a – c , e ), two-sided t -test for unpaired samples ( d ), two-tailed Wilcoxon signed-rank test ( f , g ) and two-way ANOVA with Fisher’s LSD test ( h ).

    Article Snippet: For both filter trap and western blot analyses of C. elegans , immunoblotting was performed with antibodies against GFP (AMSBIO, TP401, dilution 1:5,000), FUS (Abcam, ab154141, clone CL0190, 1:1,000) and TDP-43 (Abcam, ab225710, 1:1,000).

    Techniques: Expressing, shRNA, Construct, SDS Page, Control, Mutagenesis, Immunocytochemistry, Derivative Assay, Western Blot, Plasmid Preparation, Over Expression, Two Tailed Test

    a , Chymotrypsin-like proteasome activity in polyQ67::YFP C. elegans (relative slope to Vector RNAi, mean ± s.e.m., n = 12 biological replicates). b , Western blot of polyQ67::YFP C. elegans with anti-LGG-1/LC3 antibody. LC3-I is conjugated to phosphatidylethanolamine to form LC3-II, whose levels reflect the number of autophagosomes and autophagy-related structures. α-tubulin is the loading control. Graph represents the relative percentage values of LC3-II (corrected for α-tubulin) to Vector RNAi (mean ± s.e.m., n = 6 independent experiments). In a-b , RNAi was initiated after development and worms were analyzed at day 5 of adulthood. c , Chymotrypsin-like proteasome activity in HEK293 cells (relative slope to non-targeting (NT) shRNA, mean ± s.e.m., n = 12 biological replicates). d , Chymotrypsin-like proteasome activity in HEK293 cells expressing Q100-HTT-GFP (relative slope to NT shRNA, mean ± s.e.m., n = 11 biological replicates). e , Western blot of wild-type HEK293 cells with antibodies against LC3 and β-actin loading control. Graph represents the relative percentage values of LC3-II (corrected for β-actin) to NT shRNA (mean ± s.e.m., n = 3 independent experiments). f , Western blot of HEK293 cells expressing Q100-HTT-GFP with anti-LC3 antibody. Graph represents the relative percentage values of LC3-II (corrected for β-actin) to NT shRNA (mean ± s.e.m., n = 3 independent experiments). Statistical comparisons were made by two-tailed Student’s t -test for unpaired samples ( a ), two-tailed Wilcoxon signed-rank test ( b ), and one-way ANOVA with Dunnett’s multiple-comparison test ( c-f ).

    Journal: Nature Aging

    Article Title: The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation

    doi: 10.1038/s43587-025-00943-w

    Figure Lengend Snippet: a , Chymotrypsin-like proteasome activity in polyQ67::YFP C. elegans (relative slope to Vector RNAi, mean ± s.e.m., n = 12 biological replicates). b , Western blot of polyQ67::YFP C. elegans with anti-LGG-1/LC3 antibody. LC3-I is conjugated to phosphatidylethanolamine to form LC3-II, whose levels reflect the number of autophagosomes and autophagy-related structures. α-tubulin is the loading control. Graph represents the relative percentage values of LC3-II (corrected for α-tubulin) to Vector RNAi (mean ± s.e.m., n = 6 independent experiments). In a-b , RNAi was initiated after development and worms were analyzed at day 5 of adulthood. c , Chymotrypsin-like proteasome activity in HEK293 cells (relative slope to non-targeting (NT) shRNA, mean ± s.e.m., n = 12 biological replicates). d , Chymotrypsin-like proteasome activity in HEK293 cells expressing Q100-HTT-GFP (relative slope to NT shRNA, mean ± s.e.m., n = 11 biological replicates). e , Western blot of wild-type HEK293 cells with antibodies against LC3 and β-actin loading control. Graph represents the relative percentage values of LC3-II (corrected for β-actin) to NT shRNA (mean ± s.e.m., n = 3 independent experiments). f , Western blot of HEK293 cells expressing Q100-HTT-GFP with anti-LC3 antibody. Graph represents the relative percentage values of LC3-II (corrected for β-actin) to NT shRNA (mean ± s.e.m., n = 3 independent experiments). Statistical comparisons were made by two-tailed Student’s t -test for unpaired samples ( a ), two-tailed Wilcoxon signed-rank test ( b ), and one-way ANOVA with Dunnett’s multiple-comparison test ( c-f ).

    Article Snippet: For both filter trap and western blot analyses of C. elegans , immunoblotting was performed with antibodies against GFP (AMSBIO, TP401, dilution 1:5,000), FUS (Abcam, ab154141, clone CL0190, 1:1,000) and TDP-43 (Abcam, ab225710, 1:1,000).

    Techniques: Activity Assay, Plasmid Preparation, Western Blot, Control, shRNA, Expressing, Two Tailed Test, Comparison

    a , Filter trap of polyQ67::YFP aggregates (detected by anti-GFP antibody) in day 5 adult worms treated with 10 µM CytoD or DMSO vehicle control for 6 hours before lysis. Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin loading control) to Q67 + Vector RNAi + DMSO (mean ± s.e.m., n = 3 independent experiments). b , Filter trap with anti-GFP antibody of HEK293 human cells expressing Q23-HTT-GFP or Q100-HTT-GFP treated with 2 µM CytoD or DMSO vehicle control for 4 hours before lysis. Right: SDS-PAGE with antibodies to HTT and β-actin loading control. Graphs represent the relative percentage of aggregated and total HTT-GFP levels (corrected for β-actin) to Q23-HTT-GFP + DMSO (mean ± s.e.m., n = 3 independent experiments). c , Filter trap of mutant FUS P525L aggregates (detected by anti-FUS antibody) in day 5 adult worms treated with 10 µM CytoD for 6 hours. Right: SDS-PAGE with antibodies to FUS and α-tubulin. Graphs represent the relative percentage values of aggregated and total FUS levels (corrected for α-tubulin loading control) to FUS P525L + DMSO (mean ± s.e.m., n = 6 independent experiments). d , Filter trap of mutant TDP-43 M337V aggregates (detected by anti-TDP-43 antibody) in day 5 adult worms treated with 10 µM CytoD for 6 hours. Right: SDS-PAGE with antibodies to TDP-43 and α-tubulin. Graphs represent the relative percentage values of aggregated and total TDP-43 (corrected for α-tubulin) levels to TDP-43 M337V + DMSO (mean ± s.e.m., n = 6 independent experiments). e , Filter trap analysis of polyQ67::YFP (detected by anti-GFP antibody) in day 3 adult worms expressing endogenous WT EPS-8 or Ub-less mutant EPS-8 treated with 10 µM CytoD (6 hours). Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin) to Q67;EPS-8(WT) + DMSO (mean ± s.e.m., n = 3 independent experiments). Statistical comparisons were made by two-way ANOVA with Sidakʼs multiple comparisons test ( a ), two-way ANOVA with Fisher’s LSD test ( b , e ) and two-tailed Wilcoxon signed-rank test ( c , d ).

    Journal: Nature Aging

    Article Title: The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation

    doi: 10.1038/s43587-025-00943-w

    Figure Lengend Snippet: a , Filter trap of polyQ67::YFP aggregates (detected by anti-GFP antibody) in day 5 adult worms treated with 10 µM CytoD or DMSO vehicle control for 6 hours before lysis. Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin loading control) to Q67 + Vector RNAi + DMSO (mean ± s.e.m., n = 3 independent experiments). b , Filter trap with anti-GFP antibody of HEK293 human cells expressing Q23-HTT-GFP or Q100-HTT-GFP treated with 2 µM CytoD or DMSO vehicle control for 4 hours before lysis. Right: SDS-PAGE with antibodies to HTT and β-actin loading control. Graphs represent the relative percentage of aggregated and total HTT-GFP levels (corrected for β-actin) to Q23-HTT-GFP + DMSO (mean ± s.e.m., n = 3 independent experiments). c , Filter trap of mutant FUS P525L aggregates (detected by anti-FUS antibody) in day 5 adult worms treated with 10 µM CytoD for 6 hours. Right: SDS-PAGE with antibodies to FUS and α-tubulin. Graphs represent the relative percentage values of aggregated and total FUS levels (corrected for α-tubulin loading control) to FUS P525L + DMSO (mean ± s.e.m., n = 6 independent experiments). d , Filter trap of mutant TDP-43 M337V aggregates (detected by anti-TDP-43 antibody) in day 5 adult worms treated with 10 µM CytoD for 6 hours. Right: SDS-PAGE with antibodies to TDP-43 and α-tubulin. Graphs represent the relative percentage values of aggregated and total TDP-43 (corrected for α-tubulin) levels to TDP-43 M337V + DMSO (mean ± s.e.m., n = 6 independent experiments). e , Filter trap analysis of polyQ67::YFP (detected by anti-GFP antibody) in day 3 adult worms expressing endogenous WT EPS-8 or Ub-less mutant EPS-8 treated with 10 µM CytoD (6 hours). Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin) to Q67;EPS-8(WT) + DMSO (mean ± s.e.m., n = 3 independent experiments). Statistical comparisons were made by two-way ANOVA with Sidakʼs multiple comparisons test ( a ), two-way ANOVA with Fisher’s LSD test ( b , e ) and two-tailed Wilcoxon signed-rank test ( c , d ).

    Article Snippet: For both filter trap and western blot analyses of C. elegans , immunoblotting was performed with antibodies against GFP (AMSBIO, TP401, dilution 1:5,000), FUS (Abcam, ab154141, clone CL0190, 1:1,000) and TDP-43 (Abcam, ab225710, 1:1,000).

    Techniques: Control, Lysis, SDS Page, Plasmid Preparation, Expressing, Mutagenesis, Two Tailed Test

    Filter trap with anti-GFP antibody of Empty Vector or EPS8 overexpressing (OE) Q100-HTT-GFP HEK293. Cells were treated with 2 µM CytoD or DMSO vehicle control for 4 h before lysis. The graph represents the relative percentage of aggregated Q100-HTT levels to Empty Vector + DMSO (mean ± s.e.m., n = 3 independent experiments). Statistical comparisons were made by two-way ANOVA with Fisher’s LSD test. Right: SDS-PAGE with antibodies to EPS8 and β-actin loading control.

    Journal: Nature Aging

    Article Title: The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation

    doi: 10.1038/s43587-025-00943-w

    Figure Lengend Snippet: Filter trap with anti-GFP antibody of Empty Vector or EPS8 overexpressing (OE) Q100-HTT-GFP HEK293. Cells were treated with 2 µM CytoD or DMSO vehicle control for 4 h before lysis. The graph represents the relative percentage of aggregated Q100-HTT levels to Empty Vector + DMSO (mean ± s.e.m., n = 3 independent experiments). Statistical comparisons were made by two-way ANOVA with Fisher’s LSD test. Right: SDS-PAGE with antibodies to EPS8 and β-actin loading control.

    Article Snippet: For both filter trap and western blot analyses of C. elegans , immunoblotting was performed with antibodies against GFP (AMSBIO, TP401, dilution 1:5,000), FUS (Abcam, ab154141, clone CL0190, 1:1,000) and TDP-43 (Abcam, ab225710, 1:1,000).

    Techniques: Plasmid Preparation, Control, Lysis, SDS Page

    a , Knockdown of kgb-1 after development prevents polyQ67::YFP aggregation (detected by anti-GFP antibody) in the neurons of day 5 adult C. elegans . Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated and total polyQ67 (corrected for α-tubulin loading control) to Vector RNAi (mean ± s.e.m., n = 7 independent experiments). b , Filter trap analysis of polyQ67::YFP aggregates (detected by anti-GFP antibody) in day 3 adult worms expressing endogenous WT or Ub-less mutant EPS-8 on kgb-1 RNAi treatment. Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin loading control) to Q67;EPS-8(WT) + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). c , Knockdown of kgb-1 after development ameliorates aggregation of ALS-related mutant FUS variants in the neurons of day 5 adult worms (detected by anti-FUS antibody). Right: SDS-PAGE with antibodies to FUS and α-tubulin. Graphs represent the relative percentage values of aggregated and total FUS levels (corrected for α-tubulin loading control) to WT FUS + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). d , Knockdown of kgb-1 after development decreases TDP-43 M337V aggregation in the neurons of day 5 adult worms (detected by anti-TDP-43 antibody). Right: SDS-PAGE with antibodies to TDP-43 and α-tubulin. Graphs represent the relative percentage values of aggregated TDP-43 and total TDP-43 levels (corrected for α-tubulin loading control) to WT TDP-43 + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). Statistical comparisons were made by two-tailed Wilcoxon signed-rank test ( a ), two-way ANOVA with Fisher’s LSD test ( b , d ) and two-way ANOVA with Sidakʼs multiple comparisons test ( c ).

    Journal: Nature Aging

    Article Title: The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation

    doi: 10.1038/s43587-025-00943-w

    Figure Lengend Snippet: a , Knockdown of kgb-1 after development prevents polyQ67::YFP aggregation (detected by anti-GFP antibody) in the neurons of day 5 adult C. elegans . Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated and total polyQ67 (corrected for α-tubulin loading control) to Vector RNAi (mean ± s.e.m., n = 7 independent experiments). b , Filter trap analysis of polyQ67::YFP aggregates (detected by anti-GFP antibody) in day 3 adult worms expressing endogenous WT or Ub-less mutant EPS-8 on kgb-1 RNAi treatment. Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin loading control) to Q67;EPS-8(WT) + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). c , Knockdown of kgb-1 after development ameliorates aggregation of ALS-related mutant FUS variants in the neurons of day 5 adult worms (detected by anti-FUS antibody). Right: SDS-PAGE with antibodies to FUS and α-tubulin. Graphs represent the relative percentage values of aggregated and total FUS levels (corrected for α-tubulin loading control) to WT FUS + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). d , Knockdown of kgb-1 after development decreases TDP-43 M337V aggregation in the neurons of day 5 adult worms (detected by anti-TDP-43 antibody). Right: SDS-PAGE with antibodies to TDP-43 and α-tubulin. Graphs represent the relative percentage values of aggregated TDP-43 and total TDP-43 levels (corrected for α-tubulin loading control) to WT TDP-43 + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). Statistical comparisons were made by two-tailed Wilcoxon signed-rank test ( a ), two-way ANOVA with Fisher’s LSD test ( b , d ) and two-way ANOVA with Sidakʼs multiple comparisons test ( c ).

    Article Snippet: For both filter trap and western blot analyses of C. elegans , immunoblotting was performed with antibodies against GFP (AMSBIO, TP401, dilution 1:5,000), FUS (Abcam, ab154141, clone CL0190, 1:1,000) and TDP-43 (Abcam, ab225710, 1:1,000).

    Techniques: Knockdown, SDS Page, Control, Plasmid Preparation, Expressing, Mutagenesis, Two Tailed Test

    a , Knockdown of jnk-1 after development prevents polyQ67::YFP aggregation (detected by anti-GFP antibody) in the neurons of day-5 adult worms. Right: SDS–PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated and total polyQ67 (corrected for α-tubulin loading control) to Vector RNAi (mean ± s.e.m., n = 6 independent experiments). b , Filter trap analysis of polyQ67::YFP (detected by anti-GFP antibody) in day-3 adult worms expressing either endogenous wild-type (WT) EPS-8 or Ub-less mutant EPS-8 upon jnk-1 RNAi. Right: SDS–PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin loading control) to Q67;EPS-8(WT) + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). c , Knockdown of jnk-1 reduces aggregation of the severe FUS P525L mutant variant, but does not significantly affect aggregation of wild-type (WT) FUS or mutant FUS R522G (detected by anti-FUS antibody). Right: SDS-PAGE with antibodies to FUS and α-tubulin. Graphs represent the relative percentage values of aggregated and total FUS levels (corrected for α-tubulin loading control) to FUS WT + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). d , Knockdown of jnk-1 after development decreases TDP-43 M337V aggregation in the neurons of day-5 adult worms (detected by anti-TDP-43 antibody). Right: SDS-PAGE with antibodies to TDP-43 and α-tubulin. Graphs represent the relative percentage values of aggregated TDP-43 and total TDP-43 levels (corrected for α-tubulin loading control) to wild-type (WT) TDP-43 + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). Statistical comparisons were made by two-tailed Wilcoxon signed-rank test ( a ), two-way ANOVA with Fisher’s LSD test ( b, d ), and two-way ANOVA with Šidák multiple-comparison test ( c ).

    Journal: Nature Aging

    Article Title: The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation

    doi: 10.1038/s43587-025-00943-w

    Figure Lengend Snippet: a , Knockdown of jnk-1 after development prevents polyQ67::YFP aggregation (detected by anti-GFP antibody) in the neurons of day-5 adult worms. Right: SDS–PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated and total polyQ67 (corrected for α-tubulin loading control) to Vector RNAi (mean ± s.e.m., n = 6 independent experiments). b , Filter trap analysis of polyQ67::YFP (detected by anti-GFP antibody) in day-3 adult worms expressing either endogenous wild-type (WT) EPS-8 or Ub-less mutant EPS-8 upon jnk-1 RNAi. Right: SDS–PAGE with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin loading control) to Q67;EPS-8(WT) + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). c , Knockdown of jnk-1 reduces aggregation of the severe FUS P525L mutant variant, but does not significantly affect aggregation of wild-type (WT) FUS or mutant FUS R522G (detected by anti-FUS antibody). Right: SDS-PAGE with antibodies to FUS and α-tubulin. Graphs represent the relative percentage values of aggregated and total FUS levels (corrected for α-tubulin loading control) to FUS WT + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). d , Knockdown of jnk-1 after development decreases TDP-43 M337V aggregation in the neurons of day-5 adult worms (detected by anti-TDP-43 antibody). Right: SDS-PAGE with antibodies to TDP-43 and α-tubulin. Graphs represent the relative percentage values of aggregated TDP-43 and total TDP-43 levels (corrected for α-tubulin loading control) to wild-type (WT) TDP-43 + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). Statistical comparisons were made by two-tailed Wilcoxon signed-rank test ( a ), two-way ANOVA with Fisher’s LSD test ( b, d ), and two-way ANOVA with Šidák multiple-comparison test ( c ).

    Article Snippet: For both filter trap and western blot analyses of C. elegans , immunoblotting was performed with antibodies against GFP (AMSBIO, TP401, dilution 1:5,000), FUS (Abcam, ab154141, clone CL0190, 1:1,000) and TDP-43 (Abcam, ab225710, 1:1,000).

    Techniques: Knockdown, SDS Page, Control, Plasmid Preparation, Expressing, Mutagenesis, Variant Assay, Two Tailed Test, Comparison

    a , Inhibition of elevated DUB activity in day 5 adult worms ameliorates aggregation of neuronal polyQ67::YFP (detected by anti-GFP antibody). Right: SDS-PAGE with antibodies to GFP and α-tubulin loading control. Graphs represent the relative percentage values of aggregated and total polyQ67 levels (corrected for α-tubulin) to Q67 + DMSO vehicle control (mean ± s.e.m., n = 7 independent experiments). b , Inhibition of elevated DUB activity decreases aggregation of mutant FUS P525L in C. elegans neurons (detected by anti-FUS antibody). Right: SDS-PAGE of total FUS protein levels with anti-FUS antibody. Graphs represent the relative percentage values of aggregated and total FUS protein levels (corrected for α-tubulin) to WT FUS + DMSO vehicle control (mean ± s.e.m., n = 3 independent experiments). c , Percentage of nose touch responses/total trials in WT worms and transgenic worms expressing polyQ19 or polyQ67 in neurons (day 5 (D5): n = 80 worms per condition (except WT + DUB inhibitor, n = 79); D7: n = 40 worms per condition). d , Percentage of nose touch responses/total trials in WT worms and transgenic worms expressing WT FUS or ALS-related mutant FUS R522G and FUS P525L variants ( n = 40 worms per condition). e , Percentage of nose touch responses/total trials in WT worms and transgenic worms expressing WT TDP-43 or ALS-related mutant TDP-43 M337V variant ( n = 40 worms per condition). In c – e , the box plots represent the 25th–75th percentiles, the lines depict the median and the whiskers show the minimum–maximum values. Worms were treated with 13.7 µg ml −1 PR-619 (broad-spectrum DUB inhibitor) or vehicle control (DMSO) for 4 hours on day 5 of adulthood ( a ) or for 24 hours on day 4 of adulthood ( b – e ) and analyzed at the indicated ages. f , Single knockdown after development of csn-6 (mean ± s.e.m.: 20.56 days ± 0.62, P < 0.0001), F07A11.4 (mean ± s.e.m.: 22.16 ± 0.71, P < 0.0001) and usp-4 (mean ± s.e.m.: 20.42 ± 0.59, P < 0.0001) extends lifespan in WT worms compared with Vector RNAi controls (mean ± s.e.m.: 16.22 ± 0.44). By contrast, knockdown of usp-5 (mean ± s.e.m.: 16.66 ± 0.45, P = 0.4589), otub-3 (mean ± s.e.m.: 16.59 ± 0.46, P = 0.6532), math-33 (mean ± s.e.m.: 15.31 ± 0.36, P = 0.0552) or usp-48 (mean ± s.e.m.: 16.67 ± 0.36, P = 0.8363) does not affect lifespan. P values: two-sided log-rank test, n = 96 worms per condition. Supplementary Table contains statistical analysis and replicate data from independent lifespan experiments. g , Knockdown of usp-4 after development prevents polyQ67::YFP aggregation in day 5 adult worms (detected by anti-GFP antibody). Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graph represents the relative percentage values of aggregated and total polyQ67 protein levels (corrected for α-tubulin) to Q67 + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). Statistical comparisons were made by two-tailed Wilcoxon signed-rank test ( a ), two-way ANOVA with Fisher’s LSD test ( b ), two-way ANOVA with Sidakʼs multiple comparisons test ( c – e ), two-sided log-rank test ( f ) and one-way ANOVA with Dunnett’s multiple comparisons test ( g ).

    Journal: Nature Aging

    Article Title: The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation

    doi: 10.1038/s43587-025-00943-w

    Figure Lengend Snippet: a , Inhibition of elevated DUB activity in day 5 adult worms ameliorates aggregation of neuronal polyQ67::YFP (detected by anti-GFP antibody). Right: SDS-PAGE with antibodies to GFP and α-tubulin loading control. Graphs represent the relative percentage values of aggregated and total polyQ67 levels (corrected for α-tubulin) to Q67 + DMSO vehicle control (mean ± s.e.m., n = 7 independent experiments). b , Inhibition of elevated DUB activity decreases aggregation of mutant FUS P525L in C. elegans neurons (detected by anti-FUS antibody). Right: SDS-PAGE of total FUS protein levels with anti-FUS antibody. Graphs represent the relative percentage values of aggregated and total FUS protein levels (corrected for α-tubulin) to WT FUS + DMSO vehicle control (mean ± s.e.m., n = 3 independent experiments). c , Percentage of nose touch responses/total trials in WT worms and transgenic worms expressing polyQ19 or polyQ67 in neurons (day 5 (D5): n = 80 worms per condition (except WT + DUB inhibitor, n = 79); D7: n = 40 worms per condition). d , Percentage of nose touch responses/total trials in WT worms and transgenic worms expressing WT FUS or ALS-related mutant FUS R522G and FUS P525L variants ( n = 40 worms per condition). e , Percentage of nose touch responses/total trials in WT worms and transgenic worms expressing WT TDP-43 or ALS-related mutant TDP-43 M337V variant ( n = 40 worms per condition). In c – e , the box plots represent the 25th–75th percentiles, the lines depict the median and the whiskers show the minimum–maximum values. Worms were treated with 13.7 µg ml −1 PR-619 (broad-spectrum DUB inhibitor) or vehicle control (DMSO) for 4 hours on day 5 of adulthood ( a ) or for 24 hours on day 4 of adulthood ( b – e ) and analyzed at the indicated ages. f , Single knockdown after development of csn-6 (mean ± s.e.m.: 20.56 days ± 0.62, P < 0.0001), F07A11.4 (mean ± s.e.m.: 22.16 ± 0.71, P < 0.0001) and usp-4 (mean ± s.e.m.: 20.42 ± 0.59, P < 0.0001) extends lifespan in WT worms compared with Vector RNAi controls (mean ± s.e.m.: 16.22 ± 0.44). By contrast, knockdown of usp-5 (mean ± s.e.m.: 16.66 ± 0.45, P = 0.4589), otub-3 (mean ± s.e.m.: 16.59 ± 0.46, P = 0.6532), math-33 (mean ± s.e.m.: 15.31 ± 0.36, P = 0.0552) or usp-48 (mean ± s.e.m.: 16.67 ± 0.36, P = 0.8363) does not affect lifespan. P values: two-sided log-rank test, n = 96 worms per condition. Supplementary Table contains statistical analysis and replicate data from independent lifespan experiments. g , Knockdown of usp-4 after development prevents polyQ67::YFP aggregation in day 5 adult worms (detected by anti-GFP antibody). Right: SDS-PAGE with antibodies to GFP and α-tubulin. Graph represents the relative percentage values of aggregated and total polyQ67 protein levels (corrected for α-tubulin) to Q67 + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). Statistical comparisons were made by two-tailed Wilcoxon signed-rank test ( a ), two-way ANOVA with Fisher’s LSD test ( b ), two-way ANOVA with Sidakʼs multiple comparisons test ( c – e ), two-sided log-rank test ( f ) and one-way ANOVA with Dunnett’s multiple comparisons test ( g ).

    Article Snippet: For both filter trap and western blot analyses of C. elegans , immunoblotting was performed with antibodies against GFP (AMSBIO, TP401, dilution 1:5,000), FUS (Abcam, ab154141, clone CL0190, 1:1,000) and TDP-43 (Abcam, ab225710, 1:1,000).

    Techniques: Inhibition, Activity Assay, SDS Page, Control, Mutagenesis, Transgenic Assay, Expressing, Variant Assay, Knockdown, Plasmid Preparation, Two Tailed Test

    a , Knockdown of usp-4 ameliorates mutant FUS aggregation in the neurons of day 5 adult C. elegans (detected by anti-FUS antibody). Right: SDS-PAGE with antibodies to FUS and α-tubulin. Graphs represent the relative percentage of aggregated and total FUS levels (corrected for α-tubulin) to WT FUS + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). b , Knockdown of usp-4 decreases mutant TDP-43 M337V aggregation in day 5 adult worms (detected by anti-TDP-43 antibody). Right: SDS-PAGE with antibodies to TDP-43 and α-tubulin. Graphs represent the relative percentage of aggregated and total TDP-43 levels (corrected for α-tubulin) to TDP-43(WT) + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). c , Percentage of nose touch responses/total trials in WT worms and transgenic worms expressing polyQ19 or polyQ67 in neurons (day 1 (D1): n = 40 worms per condition; D5: n = 80; D7: n = 80). d , Chemotaxis index of neuronal polyQ-expressing worms toward 0.5% benzaldehyde (mean ± s.e.m., n = 3 independent experiments; 56–215 worms were scored per condition for each independent experiment). e , Percentage of nose touch responses/total trials in WT worms and transgenic worms expressing WT FUS or ALS-related mutant FUS R522G and FUS P525L variants (D1: n = 40 worms per condition; D5: n = 80; D7: n = 80). f , Chemotaxis index of FUS-ALS worm models toward 0.5% benzaldehyde (mean ± s.e.m., n = 3 independent experiments; 78–150 worms were scored per condition for each independent experiment). g , Percentage of nose touch responses/total trials in WT worms and transgenic worms expressing WT TDP-43 or ALS-related mutant TDP-43 M337V variant (D1: n = 30 worms per condition; D5: n = 70; D7: n = 70). In c , e , g , the box plots represent the 25th–75th percentiles, the lines depict the median and the whiskers show the minimum–maximum values. h , Western blot with antibody to EPS-8 of day 10 adult worms on usp-4 knockdown. RNAi was initiated after development. Graph: relative percentage values of EPS-8 protein levels (corrected for α-tubulin) to Vector RNAi (mean ± s.e.m., n = 6 independent experiments). i , Knockdown of usp-4 after development prolongs lifespan in worms expressing WT EPS-8 ( P < 0.01) but not the short lifespan of Ub-less EPS-8 mutants ( P = 0.6798). EPS-8(WT) + Vector RNAi: 21.01 days ± 0.46, EPS-8(WT) + usp-4 RNAi: 23.27 ± 0.40, EPS-8(Ub-less) + Vector RNAi: 17.51 ± 0.55, EPS-8(Ub-less) + usp-4 RNAi: 18.24 ± 0.48. P values: two-sided log-rank test, n = 96 worms per condition. Supplementary Table contains statistical analysis and replicate data of independent lifespan experiments. j , Knockdown of usp-4 prevents polyQ67::YFP aggregation (detected by anti-GFP antibody) in worms expressing WT EPS-8 but not in worms expressing Ub-less EPS-8 mutant. Right: western blot with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin loading control) to Q67;EPS-8(WT) + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). In all the experiments, RNAi was initiated after development. Statistical comparisons were made by two-way ANOVA with Sidakʼs multiple comparisons test ( a , c , e – g ), two-way ANOVA with Fisher’s LSD test ( b , d , j ), two-tailed Wilcoxon signed-rank test ( h ) and two-sided log-rank test ( i ).

    Journal: Nature Aging

    Article Title: The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation

    doi: 10.1038/s43587-025-00943-w

    Figure Lengend Snippet: a , Knockdown of usp-4 ameliorates mutant FUS aggregation in the neurons of day 5 adult C. elegans (detected by anti-FUS antibody). Right: SDS-PAGE with antibodies to FUS and α-tubulin. Graphs represent the relative percentage of aggregated and total FUS levels (corrected for α-tubulin) to WT FUS + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). b , Knockdown of usp-4 decreases mutant TDP-43 M337V aggregation in day 5 adult worms (detected by anti-TDP-43 antibody). Right: SDS-PAGE with antibodies to TDP-43 and α-tubulin. Graphs represent the relative percentage of aggregated and total TDP-43 levels (corrected for α-tubulin) to TDP-43(WT) + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). c , Percentage of nose touch responses/total trials in WT worms and transgenic worms expressing polyQ19 or polyQ67 in neurons (day 1 (D1): n = 40 worms per condition; D5: n = 80; D7: n = 80). d , Chemotaxis index of neuronal polyQ-expressing worms toward 0.5% benzaldehyde (mean ± s.e.m., n = 3 independent experiments; 56–215 worms were scored per condition for each independent experiment). e , Percentage of nose touch responses/total trials in WT worms and transgenic worms expressing WT FUS or ALS-related mutant FUS R522G and FUS P525L variants (D1: n = 40 worms per condition; D5: n = 80; D7: n = 80). f , Chemotaxis index of FUS-ALS worm models toward 0.5% benzaldehyde (mean ± s.e.m., n = 3 independent experiments; 78–150 worms were scored per condition for each independent experiment). g , Percentage of nose touch responses/total trials in WT worms and transgenic worms expressing WT TDP-43 or ALS-related mutant TDP-43 M337V variant (D1: n = 30 worms per condition; D5: n = 70; D7: n = 70). In c , e , g , the box plots represent the 25th–75th percentiles, the lines depict the median and the whiskers show the minimum–maximum values. h , Western blot with antibody to EPS-8 of day 10 adult worms on usp-4 knockdown. RNAi was initiated after development. Graph: relative percentage values of EPS-8 protein levels (corrected for α-tubulin) to Vector RNAi (mean ± s.e.m., n = 6 independent experiments). i , Knockdown of usp-4 after development prolongs lifespan in worms expressing WT EPS-8 ( P < 0.01) but not the short lifespan of Ub-less EPS-8 mutants ( P = 0.6798). EPS-8(WT) + Vector RNAi: 21.01 days ± 0.46, EPS-8(WT) + usp-4 RNAi: 23.27 ± 0.40, EPS-8(Ub-less) + Vector RNAi: 17.51 ± 0.55, EPS-8(Ub-less) + usp-4 RNAi: 18.24 ± 0.48. P values: two-sided log-rank test, n = 96 worms per condition. Supplementary Table contains statistical analysis and replicate data of independent lifespan experiments. j , Knockdown of usp-4 prevents polyQ67::YFP aggregation (detected by anti-GFP antibody) in worms expressing WT EPS-8 but not in worms expressing Ub-less EPS-8 mutant. Right: western blot with antibodies to GFP and α-tubulin. Graphs represent the relative percentage values of aggregated polyQ67 and total polyQ67 levels (corrected for α-tubulin loading control) to Q67;EPS-8(WT) + Vector RNAi (mean ± s.e.m., n = 3 independent experiments). In all the experiments, RNAi was initiated after development. Statistical comparisons were made by two-way ANOVA with Sidakʼs multiple comparisons test ( a , c , e – g ), two-way ANOVA with Fisher’s LSD test ( b , d , j ), two-tailed Wilcoxon signed-rank test ( h ) and two-sided log-rank test ( i ).

    Article Snippet: For both filter trap and western blot analyses of C. elegans , immunoblotting was performed with antibodies against GFP (AMSBIO, TP401, dilution 1:5,000), FUS (Abcam, ab154141, clone CL0190, 1:1,000) and TDP-43 (Abcam, ab225710, 1:1,000).

    Techniques: Knockdown, Mutagenesis, SDS Page, Plasmid Preparation, Transgenic Assay, Expressing, Chemotaxis Assay, Variant Assay, Western Blot, Control, Two Tailed Test

    a , Western blot analysis of EPS8 levels in HEK293 cells expressing control NT or USP4 shRNA. Cells were treated with 0.5 µM MG-132 proteasome inhibitor or DMSO vehicle control for 16 hours before the lysis. β-Actin is the loading control. Representative of three independent experiments. b , Co-IP with control IgG and antibody against USP4 in HEK293 cells. Co-IP was followed by western blot with antibodies to USP4 and EPS8. Representative of two independent experiments. c , Filter trap with anti-GFP of HEK293 cells expressing either control Q23-HTT-GFP or aggregation-prone Q100-HTT-GFP upon knockdown of USP4 using two independent shRNAs. Right: SDS-PAGE with antibodies to HTT, EPS8, USP4 and β-actin loading control. Graphs: mean ± s.e.m. relative percentage of aggregated Q100-HTT and total Q100-HTT or EPS8 levels (corrected for β-actin) to NT shRNA Q100-HTT cells (mean ± s.e.m., n = 3 independent experiments). d , Filter trap of Q100-HTT-GFP aggregation (detected with anti-GFP antibody) in HEK293 cells upon knockdown of USP4 and overexpression of EPS8. Right: SDS-PAGE with antibodies to HTT, EPS8, USP4 and β-actin loading control. Graphs: mean ± s.e.m. relative percentage of aggregated and total Q100-HTT levels (corrected for β-actin) to NT shRNA Q100-HTT cells (mean ± s.e.m., n = 3 independent experiments). e , Filter trap with anti-FUS of HEK293 cells expressing aggregation-prone FUS P525L upon knockdown of USP4. Right: SDS-PAGE with antibodies to FUS, EPS8, USP4 and β-actin loading control. Graphs: mean ± s.e.m. relative percentage of aggregated FUS and total FUS or EPS8 levels (corrected for β-actin) to NT shRNA cells (mean ± s.e.m., n = 4 independent experiments). f , Filter trap with anti-TDP-43 antibody of HEK293 cells expressing aggregation-prone mutant TDP-43 A382T upon knockdown of USP4. Right: SDS-PAGE with antibodies to TDP-43, EPS8, USP4 and β-actin loading control. Graphs: mean ± s.e.m. relative percentage of aggregated TDP-43 and total TDP-43 or EPS8 levels (corrected for β-actin) to NT shRNA cells (mean ± s.e.m., n = 3 independent experiments). g , Immunocytochemistry of FUS(P525L) ALS iPSC-derived motor neurons with anti-cleaved caspase-3 (red), anti-MAP2 (green) and Hoechst (nucleus, blue). Scale bar, 20 µm. Graph represents the percentage of cleaved caspase-3-positive cells/total nuclei (mean ± s.e.m. of four biological replicates from two independent experiments, NT shRNA: 185 total nuclei; USP4 shRNA 1: 149 total nuclei; USP4 shRNA 2: 147 total nuclei). Statistical comparisons were made by one-way ANOVA with Dunnett’s multiple comparisons test ( c , e – g ) and two-way ANOVA with Tukeyʼs multiple comparisons test ( d ).

    Journal: Nature Aging

    Article Title: The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation

    doi: 10.1038/s43587-025-00943-w

    Figure Lengend Snippet: a , Western blot analysis of EPS8 levels in HEK293 cells expressing control NT or USP4 shRNA. Cells were treated with 0.5 µM MG-132 proteasome inhibitor or DMSO vehicle control for 16 hours before the lysis. β-Actin is the loading control. Representative of three independent experiments. b , Co-IP with control IgG and antibody against USP4 in HEK293 cells. Co-IP was followed by western blot with antibodies to USP4 and EPS8. Representative of two independent experiments. c , Filter trap with anti-GFP of HEK293 cells expressing either control Q23-HTT-GFP or aggregation-prone Q100-HTT-GFP upon knockdown of USP4 using two independent shRNAs. Right: SDS-PAGE with antibodies to HTT, EPS8, USP4 and β-actin loading control. Graphs: mean ± s.e.m. relative percentage of aggregated Q100-HTT and total Q100-HTT or EPS8 levels (corrected for β-actin) to NT shRNA Q100-HTT cells (mean ± s.e.m., n = 3 independent experiments). d , Filter trap of Q100-HTT-GFP aggregation (detected with anti-GFP antibody) in HEK293 cells upon knockdown of USP4 and overexpression of EPS8. Right: SDS-PAGE with antibodies to HTT, EPS8, USP4 and β-actin loading control. Graphs: mean ± s.e.m. relative percentage of aggregated and total Q100-HTT levels (corrected for β-actin) to NT shRNA Q100-HTT cells (mean ± s.e.m., n = 3 independent experiments). e , Filter trap with anti-FUS of HEK293 cells expressing aggregation-prone FUS P525L upon knockdown of USP4. Right: SDS-PAGE with antibodies to FUS, EPS8, USP4 and β-actin loading control. Graphs: mean ± s.e.m. relative percentage of aggregated FUS and total FUS or EPS8 levels (corrected for β-actin) to NT shRNA cells (mean ± s.e.m., n = 4 independent experiments). f , Filter trap with anti-TDP-43 antibody of HEK293 cells expressing aggregation-prone mutant TDP-43 A382T upon knockdown of USP4. Right: SDS-PAGE with antibodies to TDP-43, EPS8, USP4 and β-actin loading control. Graphs: mean ± s.e.m. relative percentage of aggregated TDP-43 and total TDP-43 or EPS8 levels (corrected for β-actin) to NT shRNA cells (mean ± s.e.m., n = 3 independent experiments). g , Immunocytochemistry of FUS(P525L) ALS iPSC-derived motor neurons with anti-cleaved caspase-3 (red), anti-MAP2 (green) and Hoechst (nucleus, blue). Scale bar, 20 µm. Graph represents the percentage of cleaved caspase-3-positive cells/total nuclei (mean ± s.e.m. of four biological replicates from two independent experiments, NT shRNA: 185 total nuclei; USP4 shRNA 1: 149 total nuclei; USP4 shRNA 2: 147 total nuclei). Statistical comparisons were made by one-way ANOVA with Dunnett’s multiple comparisons test ( c , e – g ) and two-way ANOVA with Tukeyʼs multiple comparisons test ( d ).

    Article Snippet: For both filter trap and western blot analyses of C. elegans , immunoblotting was performed with antibodies against GFP (AMSBIO, TP401, dilution 1:5,000), FUS (Abcam, ab154141, clone CL0190, 1:1,000) and TDP-43 (Abcam, ab225710, 1:1,000).

    Techniques: Western Blot, Expressing, Control, shRNA, Lysis, Co-Immunoprecipitation Assay, Knockdown, SDS Page, Over Expression, Mutagenesis, Immunocytochemistry, Derivative Assay